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Objectives Periodontal disease is an inflammatory condition of the tooth-supporting structures. Leptin is a hormone 
produced by the human body under different circumstances such as infection. It affects the production of cytokines, 
phagocytosis and the inflammation process. This study aimed to compare the salivary level of leptin in chronic 
periodontitis (CP) patients and healthy controls. 
Methods In this case-control study, saliva samples were collected from 43 subjects including 22 CP patients and 21 
healthy controls. The salivary level of leptin was determined using the ELISA. Data were analyzed by the independent t-
test. 
Results Despite the presence of leptin in the saliva of CP patients and healthy controls, no significant difference was 
noted in its salivary concentration between the two groups (p>0.05). 
Conclusion The salivary level of leptin in CP patients was not significantly different from that in healthy controls. Further 
studies with larger sample size are required to confirm the results of this study.   




Chronic periodontitis (CP) is a chronic inflammatory 
condition with a bacterial origin. It occurs as the result of an 
imbalance between the bacteria present in dental biofilm 
and the host inflammatory immune response.
1
 Destruction 
of periodontal tissue subsequently occurs as the result of 
release of pro-inflammatory mediators such as interleukin 
1B, tumor necrosis factor alpha, and prostaglandin E2. 
These mediators cause destruction of periodontal fibers as 
well as bone resorption.
2 
Assessment of the level of 
biomarkers in the saliva, serum, blood and gingival 
crevicular fluid (GCF) has the potential for detection and 
diagnosis of periodontal disease independent of the clinical 
and radiographic findings.  
Saliva is a biological fluid that contains a number of 
biomolecules. It is easily accessible and enables the 
assessment of the level of biomarkers that are constantly 
present in the saliva and those entered into the saliva from 
the blood circulation of the gingival tissues due to the 
presence of a systemic condition.
3-5
 Leptin is a non-
glycosidic hormone, which is produced in large amounts by 
the adipocytes
6,7










intralobular duct cells of the major salivary glands.
12
 They 
have properties similar to those of cytokines in the process 
of inflammation.
13
 The main role of leptin is to balance the 
energy in the human body. It also plays a role in thermal 
regulation of the body, bone metabolism, process of 
inflammation and host defense mechanisms.
14
 Evidence 
shows that leptin helps in higher production of cytokines 
and phagocytosis by the macrophages.
15
 Some studies have 
reported lower concentration of leptin in the GCF and 
serum of patients with CP compared to healthy controls.
16-18
 
Considering the confirmed role of adipokines such as leptin 
in resolution of inflammation, this study aimed to assess 
and compare the concentration of leptin in the saliva of CP 
patients and healthy controls using the ELISA.  
  
Materials and Methods 
This case-control study (Ethics Number: 
IR.SBMU.RIDS.REC.1395.304) evaluated 43 subjects (20 
males and 23 females, aged between 22 to 60 years) 
including 22 patients with CP and 21 periodontally healthy 
controls. All subjects signed informed consent forms prior 
to participation in the study. Periodontal patients were 
selected according to the criteria set by the American 
Academy of Periodontology in 1999. The patients had to 
have a minimum of two teeth with pocket depth≥5 mm, 
clinical attachment loss≥4 mm and positive bleeding on 
probing. The healthy controls had gingival index<1 mm, 
probing pocket depth<3 mm and no clinical attachment 
loss. 
Sample collection: 
Unstimulated saliva samples were collected from all 
individuals between 10 a.m. to 12 p.m. The subjects were 
requested to refrain from eating and drinking for a 
minimum of 2 hours prior to sample collection. They were 
asked to rinse their mouth with water for one minute prior 
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to saliva collection. The oral cavity was then examined to 
ensure absence of debris. After 15 minutes, the subjects 
were requested to swallow their saliva and then spit into 
sterile test tubes every one minute for five minutes. The 
saliva samples were then centrifuged with 4000 g for 15 
minutes at 4°C on the same day to separate the viscous 
portion of the saliva from the particles. The supernatant was 
removed by a sampler, transferred to microtubes (200 µL in 
each tube) and stored at -70°C until the experiment. 
Detection of leptin: 
An ELISA kit was used to determine the salivary 
concentration of leptin. All procedures were performed 
according to the manufacturer’s instructions. The optical 
density was measured at 405 nm (the reference wavelength 
was 630 nm). The salivary concentration of leptin was 
determined by comparing the mean optical density of 
samples with the standard curve.  
Statistical analysis 
Data were analyzed using SPSS version 22 (SPSS Inc., IL, 
USA). The salivary concentration of leptin was compared 
between the two groups using the independent t-test. p<0.05 
was considered statistically significant. The salivary 
concentration of leptin was reported as the mean and 
standard deviation values.  
 
Results 
Mean value of salivary concentration of leptin are shown in 
table1 and Fig 1. Despite the presence of leptin in the saliva 
of CP patients and healthy controls, the difference in the 
mean salivary level of leptin was not significant between 
CP patients and healthy controls (p=0.141).  







Mean (SD) Mean (SD) p-value 
Leptin 
(ng/ml) 
0.17±0.2 0.32±0.06 0.141 
 
 
Figure 1- Comparison of salivary levels of leptin in study 
groups 
Discussion 
Oral cavity has several defense mechanisms that prevent 
entry of pathogens into the human body. Saliva and GCF 
are the main defense systems in the oral cavity since they 
contain several defense molecules that play a protective 
role. A high number of protective proteins and cytokines 
are found in the saliva, which play a role in innate and 
acquired immunity as well as inflammatory mechanisms.
19
 
Leptin is a peptide hormone that not only protects the 
adipocytes and regulates the metabolism, but also affects 
the endothelial, macrophage and T-cells and plays an 
important role in body defense via humoral and cellular 
immunity.
20
 Leptin, present in the oral cavity as a cytokine, 
can decrease the secretion of mucin from the salivary 
glands. This reduction in mucin decreases the activity of 
bacteria. This is important considering the role of bacteria 
in periodontitis.
21
 Moreover; leptin plays an important role 
in bone metabolism. It stimulates osteoblasts and induces 
their differentiation into mature bone cells with osteogenic 
potential. This is particularly important since bone loss is a 
common complication of CP.
22-24 
Leptin acts as an 
inflammatory cytokine and triggers the immune system. 
Thus, its concentration often changes at the time of 
infection and inflammation. Periodontal disease is an 
inflammatory infectious condition, and bacteria such as 
Aggregatibacter actinomycetemcomitans and 
Porphyromonas gingivalis are involved in its occurrence. 




Considering the available information regarding leptin, we 
hypothesized that the salivary level of leptin would 
decrease in CP patients. However, our study failed to find 
any significant difference in the salivary level of leptin 
between CP patients and healthy controls (p>0.05). The 
salivary level of leptin had a wide variation in our CP group 
ranging from 0.02 ng to 0.51 ng. Although the mean value 
in patients (0.23) was higher than that in the control group, 
since the standard deviation was also high (0.18), the 
difference between the two groups did not reach statistical 
significance. The salivary level of leptin in the control 
group ranged from 0.10 ng to 0.26 ng. The mean value was 
0.17 and the standard deviation was 0.05. Such variations in 
the salivary level of leptin can be due to unknown systemic 
conditions, although we excluded the patients with systemic 
diseases. It may also be due to the variations in the host 
immune response in different individuals. Khorsand et al. 
(2016) reported that the salivary level of leptin in 16 
patients with aggressive periodontitis was lower than that in 
healthy individuals.
29
 In their study, patients had aggressive 
periodontitis and the microorganisms involved in 
aggressive periodontitis are different from those involved in 
CP. Also, aggressive periodontitis has a much faster pace 
than CP. In the study by Sabir and Ahmed (2015) the 
salivary level of leptin in healthy controls was higher than 
that in CP patients, which was different from our finding. 
Original Article 
Salivary Level of Leptin in Chronic Periodontitis                           Zeinab Rezaei Esfahrood, et al.                                                                                                                                                            
 
 
19   Journal Dental School; Vol 37, No.1, Winter 2019; 17-20  
However, the difference in salivary level of leptin between 
CP patients and healthy controls was very small (0.16 ng) in 
their study.
30
 Purwar et al. (2015) indicated that the salivary 
level of leptin in CP patients was lower than that in healthy 
controls.
31
 Difference between their results and ours may be 
due to the use of a different ELISA kit with lower accuracy 
in their study compared to ours. Also, racial differences in 
host response may explain the variability in the results.  
The role of inflammatory biomarkers present in the saliva in 
diagnosis of periodontitis has attracted attention in the 
recent decades. However, search of the literature by the 
authors yielded only one previous study comparing the 
salivary level of leptin in CP patients and healthy controls. 
Saliva is easily accessible and its analysis for biomarkers is 
much easier than the assessment of biomarkers in the 
serum. This technique is cost-effective and yields valuable 
results. 
Conclusion 
According to the obtained results, leptin was present in the 
saliva of both CP patients and healthy controls and no 
significant difference was noted in its concentration 
between the two groups. Further studies with larger sample 
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